Navigation Links
The AACR to host molecular diagnostics conference
Date:9/21/2010

DENVER The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

Recent advances in genomics, proteomics, molecular imaging and other new technologies are leading to a molecularly based reclassification of cancer. These approaches allow for a more precise understanding of a patient's tumor and a more personalized, targeted approach to therapy.

"This emerging understanding, together with the enhanced ability to characterize tumors from individual patients, creates many opportunities for improved treatment of malignancy and accelerated development of new therapeutics," said Program Chairperson Gordon B. Mills, M.D., Ph.D., chair of the department of systems biology at the University of Texas MD Anderson Cancer Center.

Mills will host a press conference on some of the new diagnostic methods under development on Sept. 28, at 1:00 p.m. MT.

The following are press releases, which are based on research that will be highlighted during the press conference:

  • Triple-negative Breast Cancers May Have Unique Therapeutic Target
  • Circulating Tumor Cells Can Provide "Real-time" Information on Patient's Current Disease State
  • Biomarker Panel Identifies Prostate Cancer with 90 Percent Accuracy
  • New Biomarkers Discovered for Pancreatic Cancer and Mesothelioma

Reporters who cannot attend the press conference in person can call in using the following information:

  • U.S. and Canada: (888) 282-7404
  • International: (706) 679-5207
  • Access Code: 97080252

The AACR Communication Department is also highlighting the following research, which will be presented at the meeting:

  • African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy
  • Novel Test Following Prostate Surgery Could Detect Cancer Recurrence Earlier
  • MicroRNA Panel Provides a More Precise Lung Cancer Diagnosis
  • Screening Tool Can Detect Colorectal Cancer from a Small Blood Sample
  • Novel Biomarker May Predict Response to New VEGF Receptor Inhibitor
  • Nanotechnology Brings Personalized Therapy One Step Closer to Reality
  • Dual-capture CTC Chip Efficiently Captures Breast Cancer Cells
  • Method to Detect Bladder Cancer Earlier is Under Development
  • c-Met May Be a Biomarker for Metastatic Hepatocellular Carcinoma


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Would a molecular horse trot, pace or glide across a surface?
2. American Society for Biochemistry and Molecular Biology reacts to stem-cell ruling
3. Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets
4. Genome comparison of ants establishes new model species for molecular research
5. University of Maryland receives $1.9M from NSF for investigations of biomolecular structure
6. Swimming upstream: Molecular approaches to better understand male infertility
7. New molecular signaling cascade increases glucose uptake
8. AACR hosts molecular diagnostics conference in Denver, Colo.
9. American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists
10. WPI research shows how cranberry juice fights bacteria at the molecular level
11. Molecular biology provides clues to health benefits of olive oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: